【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 28
3.1.3 Melanoma Biomarkers 29
3.2 Clinical Staging 30
3.3 Symptoms 32
3.4 Prognosis 32
3.5 Quality of Life 34
4 Epidemiology 35
4.1 Disease Background 35
4.2 Risk Factors and Comorbidities 35
4.3 Global Trends 38
4.3.1 US 39
4.3.2 5EU 39
4.3.3 Japan and Australia 39
4.4 Forecast Methodology 40
4.4.1 Sources Used 42
4.4.2 Sources Not Used 49
4.4.3 Forecast Assumptions and Methods 49
4.5 Epidemiological Forecast for Melanoma (2013-2023) 52
4.5.1 Diagnosed Incident Cases of Melanoma 52
4.5.2 Age-Specific Diagnosed Incident Cases of Melanoma 54
4.5.3 Sex-Specific Diagnosed Incident Cases of Melanoma Skin Cancer 56
4.5.4 Age-Standardized Diagnosed Incidence Rates 58
4.5.5 Pathological Stage at Diagnosis 60
4.5.6 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer 61
4.5.7 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer by Genetic Aberrations 63
4.6 Discussion 65
4.6.1 Epidemiological Forecast Insight 65
4.6.2 Limitations of the Analysis 66
4.6.3 Strengths of the Analysis 67
5 Disease Management 68
5.1 Diagnosis Overview 68
5.2 Treatment Overview 69
5.2.1 Localized Melanoma: Stage 0 to Stage IIC 71
5.2.2 Regional Melanoma: Stage IIIA to Stage IIIC 72
5.2.3 Unresectable and Metastatic Melanoma: Stage III and Stage IV 75
5.3 US 81
5.3.1 Screening and Diagnosis 82
5.3.2 Clinical Practices 84
5.4 France 86
5.4.1 Screening and Diagnosis 87
5.4.2 Clinical Practices 87
5.5 Germany 88
5.5.1 Screening and Diagnosis 89
5.5.2 Clinical Practices 90
5.6 Italy 93
5.6.1 Screening and Diagnosis 94
5.6.2 Clinical Practices 94
5.7 Spain 96
5.7.1 Screening and Diagnosis 97
5.7.2 Clinical Practices 97
5.8 UK 98
5.8.1 Screening and Diagnosis 99
5.8.2 Clinical Practices 99
5.9 Japan 101
5.9.1 Screening and Diagnosis 101
5.9.2 Clinical Practices 102
5.10 Australia 103
5.10.1 Screening and Diagnosis 104
5.10.2 Clinical Practices 105
6 Competitive Assessment 108
6.1 Overview 108
6.2 Interferon-based Adjuvant Therapies 110
6.2.1 Roferon-A (Interferon Alfa-2a) 110
6.2.2 Intron A (Interferon Alfa-2b) 114
6.2.3 Sylatron (Peginterferon Alfa-2b) 118
6.3 Immune Checkpoint Inhibitors 124
6.3.1 Yervoy (Ipilimumab) 124
6.3.2 Opdivo (Nivolumab) 134
6.3.3 Keytruda (Pembrolizumab) 143
6.4 BRAF Mutation-targeted Therapies 151
6.4.1 Zelboraf (Vemurafenib) 151
6.4.2 Tafinlar (Dabrafenib) 158
6.4.3 Mekinist (Trametinib) 164
6.5 Other Therapeutic Classes 176
7 Unmet Need and Opportunity 178
7.1 Overview 178
7.2 Therapeutic Options for BRAF Wild-Type Patients 180
7.2.1 Unmet Need 180
7.2.2 Gap Analysis 181
7.2.3 Opportunity 182
7.3 Therapies for Non-responders to PD-1 Immunotherapy 183
7.3.1 Unmet Need 183
7.3.2 Gap Analysis 184
7.3.3 Opportunity 186
7.4 Adjuvant Therapies for High-Risk Resectable Melanoma 188
7.4.1 Unmet Need 188
7.4.2 Gap Analysis 189
7.4.3 Opportunity 191
7.5 Effective Treatment for Brain Metastases 193
7.5.1 Unmet Need 193
7.5.2 Gap Analysis 194
7.5.3 Opportunity 196
7.6 Predictive Markers for Therapeutic Response to Immunotherapies 197
7.6.1 Unmet Need 197
7.6.2 Gap Analysis 198
7.6.3 Opportunity 200
8 Pipeline Assessment 201
8.1 Overview 201
8.2 Promising Drugs in Clinical Development 202
8.3 RAF/RAS/MEK Pathway-Targeting Therapies 204
8.3.1 Cobimetinib (GDC-0973) 204
8.3.2 Encorafenib (LGX818) 211
8.3.3 Binimetinib (MEK162) 217
8.4 Immune-Related Therapies 224
8.4.1 Talimogene Laherparepvec 224
8.4.2 Eltrapuldencel-T (NSB20) 232
8.4.3 Seviprotimut-L (POL-103A) 238
8.4.4 PV-10 244
8.5 Promising Drugs in Early-Stage Development 250
8.5.1 PI3K/Akt/mTOR Pathway-Targeting Therapies 250
8.5.2 Cell Cycle Checkpoint Inhibitors 252
8.5.3 Next-Generation BRAF Inhibitors 254
8.5.4 Immunotherapies 256
8.5.5 Antibody-Drug Conjugates 259
8.6 Other Drugs in Development 261
9 Current and Future Players 263
9.1 Overview 263
9.2 Trends in Corporate Strategy 266
9.3 Company Profiles 267
9.3.1 Bristol-Myers Squibb 267
9.3.2 Novartis 270
9.3.3 Roche 273
9.3.4 Merck 276
10 Market Outlook 280
10.1 Global Markets 280
10.1.1 Forecast 280
10.1.2 Drivers and Barriers — Global Issues 284
10.2 United States 286
10.2.1 Forecast 286
10.2.2 Key Events 290
10.2.3 Drivers and Barriers — US 291
10.3 5EU 293
10.3.1 Forecast 293
10.3.2 Key Events 297
10.3.3 Drivers and Barriers — France 298
10.3.4 Drivers and Barriers — Germany 300
10.3.5 Drivers and Barriers — Italy 301
10.3.6 Drivers and Barriers — Spain 303
10.3.7 Drivers and Barriers — UK 304
10.4 Japan 306
10.4.1 Forecast 306
10.4.2 Key Events 309
10.4.3 Drivers and Barriers — Japan 309
10.5 Australia 311
10.5.1 Forecast 311
10.5.2 Key Events 314
10.5.3 Drivers and Barriers — Australia 315
11 Appendix 317
11.1 Bibliography 317
11.2 Abbreviations 344
11.3 Methodology 349
11.4 Forecasting Methodology 349
11.4.1 Diagnosed Melanoma Patients 349
11.4.2 Percent Drug-Treated Patients 350
11.4.3 Drugs Included in Each Therapeutic Class 350
11.4.4 Launch and Patent Expiry Dates 351
11.4.5 General Pricing Assumptions 352
11.4.6 Average Body Weight and Surface Area Across the 8MM 353
11.4.7 Individual Drug Assumptions 354
11.4.8 Generic Erosion 368
11.4.9 Pricing of Pipeline Agents 368
11.5 Primary Research – KOLs Interviewed for this Report 370
11.6 Primary Research – Prescriber Survey 373
11.7 About the Authors 374
11.7.1 Analyst 374
11.7.2 Therapy Area Director 374
11.7.3 Epidemiologist 375
11.7.4 Global Head of Healthcare 375
11.8 About GlobalData 376
11.9 Disclaimer 376
【レポート販売概要】
■ タイトル:黒色腫治療薬の世界市場予測および分析■ 英文:PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2015年4月5日
■ 調査会社:GlobalData
■ 商品コード:GDHC104PIDR
■ 調査対象地域:グローバル
- タブレットPCの世界市場:OS別、画面サイズ別、地域別分析About Tablets A tablet is a mobile computer device that is larger than a smartphone or a phablet and smaller than a laptop. Its screen size is generally larger than seven inches. It has a touch screen that can be controlled with the touch of a stylus or a finger. It does not require a keyboard or a mouse and offers greater mobility than a normal laptop. Tablets have long battery life of up to 10 h …
- Topical Clonidine(神経因性疼痛):医薬品市場予測及び分析(~2022)Topical Clonidine (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. A …
- 鋳鋼の世界市場2016-2020About Steel Casting A steel casting is a method where liquefied steel is poured into a mold, made of sand or ceramic plaster, to create a desired shape. The mold contains a hollow cavity of the required shape. After pouring the liquefied steel cools, solidifies, and is removed for cleaning. The product formed is subjected to heat treatment and further finishing. Heat treatment enhances the propert …
- データセンターSANの世界市場2016-2020About Data Center SAN SAN is a high-speed network of storage devices connected to the server. It provides block level data storage for applications running on networked servers. At the block level, it allows multiple server computers connect to one storage device. Simultaneous access to a particular storage within the storage device is not permitted in SAN systems. However, they allow a server to …
- 自動車用カーボンセラミックブレーキローターの世界市場2017-2021About Automotive Carbon Ceramic Brake RotorsA ceramic brake rotor is made of ceramic, which is an inorganic solid material. It is very hard yet light, stable, and water resistant. These rotors are one of the superior high-performance braking systems that are commercially available in the market. They help to overcome the drawbacks of iron brake rotors, offering optimum braking performance in sport …
- 低温クーラーの世界市場:ギフォード・マクマホン冷凍機、パルス管冷凍機、スターリング冷凍機、ジュール・トムソン冷凍機、ブレイトン冷凍機The global cryocooler market is expected to grow from USD 1.76 Billion in 2015 to USD 2.94 Billion by 2022, at a CAGR of 7.29% between 2016 and 2022. The market is majorly driven by the growing medical & healthcare services in developing economies and rapid shortage of helium gas. In addition, factors such as growing demand for cryocoolers in space applications and development of cryocoolers for m …
- 中国の子供用フットウェア(靴)市場2015-2019Technavios research analyst predicts the childrens footwear market in China to grow at a CAGR of 12% during the forecast period. The frequent need to replace footwear due to the change in foot size is driving the growth of this market. Many children suffer foot problems by their early teens, often associated with ill-fitting shoes. The growth of e-commerce in China is also driving the market growt …
- 排熱回収装置の世界市場動向・予測(~2021年)The market size of waste heat recovery system (WHRS) was USD 44.14 Billion in 2015, and is projected to reach USD 65.87 Billion by 2021, at a CAGR of 6.90% between 2016 and 2021. The focus on cost efficiency and stringent government regulations are expected to drive the demand for the WHR system market. The steam & electricity generation application segment dominated the WHR system market in 2015. …
- 未来の通信市場トレンド及びシナリオThis report projects the challenges for telecommunications operators for the 2025 horizon. It analyzes use and market trends as well as ongoing structural changes in the industry to show a long-term vision of the role of operators. Finally, it offers a market calculation for 2025, according to three scenarios. The countries analyzed are: France, Germany, Italy, Japan, Spain, the United Kingdom and …
- アクティブ光ケーブルの世界市場動向・予測(~2020)The active optical cable market is estimated to exhibit high growth till 2022. The overall market is expected to reach USD 3.43 Billion by 2022, at a CAGR of 27.1% between 2016 and 2022. Increase adaption in the data center market as well as the digital signage industry is expected to drive the active optical cable market. Data center is expected to lead the end user application of the active opti …
- ドキソルビシンの世界市場分析:用途別(卵巣がん、多発性骨髄腫、カポジ肉腫、白血病、骨肉腫、乳房、子宮内膜がん、胃がん、肝臓がん、腎臓がん、他のがん)、セグメント予測、2013 – 2024The global doxorubicin market was valued at USD 0.81 billion in 2015 and is expected to reach a value of USD 1.38 billion by 2024, according to a new report by Grand View Research, Inc. The growing number of players in the market to control the shortage of the drug is one of the crucial factors that is expected to drive the market in the coming few years. Some of the doxorubicin manufacturers are …
- IoTエンジニアリングサービスの世界市場予測(~2022年):製品エンジニアリング、クラウド・プラットフォームエンジニアリング、UI/UXデザイン、分析、セキュリティ、メインテナンス、サービスThe IoT engineering services market size is estimated to grow at a CAGR of 24.5% during the forecast periodThe IoT engineering services market size is expected to grow from USD 9.87 billion in 2017 to USD 29.53 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 24.5% during the forecast period. The market is said to be driven by the growing need for reduced system troubleshooting and enha …
- スポーツアナリティクスの世界市場:コンポーネント別(ソリューション、サービス)、展開モード別(オンプレミス、クラウド)、用途別(マーケティング/販売、ビデオ分析、ファンエンゲージメント、チームパフォーマンスとトレーニングスポーツ、プレーヤー分析と健康評価)Sports analytics is the method of applying data gathered from a team performance under various circumstances for improving the performance of the team and helping in better decision-making. It is the collection of historical statistics that when used appropriately can provide a viable advantage to an individual or to the team. Through the collection and analyzation of these data, sports analytics …
- グローバル製薬市場におけるライフサイクル管理(LCM)戦略GBI Research’s latest report, "Life Cycle Management Strategies - Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides …
- Seroquel XR (大うつ病性障害):医薬品市場予測及び分析(~2023)Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …